Weise, Christopher M.
Engel, Annerose
Polyakova, Maryna
Wu, Qiong
Mueller, Karsten
Herzig, Sabine
Jech, Robert
Diehl-Schmid, Janine
Riedl, Lina
Anderl-Straub, Sarah
Kornhuber, Johannes
Fassbender, Klaus
Wiltfang, Jens
Fliessbach, Klaus
Prudlo, Johannes
Synofzik, Matthis
Danek, Adrian
Otto, Markus
Schroeter, Matthias L.
,
Böhm, Fabiola
Söntgerath, Marie
Hüper, Lea
Marschhauser, Anke
Pino, Danièle
Regenbrecht, Frank
Thöne-Otto, Angelika
Roßmeier, Carola
Werner, Leonie
Maler, Juan Manuel
Richter-Schmidinger, Tanja
Hammer-Kaspereit, Anke
Oberstein, Timo
Funding for this research was provided by:
German Federal Ministry of Education and Research (FTLDc 01GI1007A, FTLDc 01GI1007A, FTLDc 01GI1007A)
EU Joint Program-Neurodegenerative Diseases networks Genfi-Prox (01ED2008A)
EU Moodmarker program (01EW2008)
Foundation of the state Baden-Württemberg (D.3830)
Boehringer Ingelheim Ulm University BioCenter (D.5009)
Fondation Thierry Latran (D.2468)
Deutsche Forschungsgemeinschaft (SCHR 774/5-1)
eHealthSax Initiative of the Sächsische Aufbaubank (project TelDem)
Martin-Luther-Universität Halle-Wittenberg
Article History
Received: 7 May 2024
Accepted: 2 October 2024
First Online: 26 October 2024
Declarations
:
: The study was approved by the ethics committees of all Universities contributing patients and controls, and was in accordance with the latest version of the Declaration of Helsinki (ethics committee Leipzig ID 137-11-18042011). Each participant provided written informed consent.
: Not applicable.
: The authors declare no competing interests.